Key result
Thrombolysis-induced intracerebral hemorrhage in stroke typically occurs within 24 to 36 hours, demanding complex management.
Answers are grounded in this paper and cite their sources.
Intracerebral hemorrhage (ICH) secondary to intravenous and intraarterial revascularization strategies for emergent treatment of acute ischemic stroke is associated with high mortality. ICH from systemic thrombolysis typically occurs within the first 24-36 hours of treatment initiation and is characterized by rapid hematoma development and growth. Pathophysiological mechanisms of revascularization therapy-induced ICH are complex and involve a combination of several distinct processes, including the direct effect of thrombolytic agents, disruption of the blood-brain barrier secondary to ischemia, and direct vessel damage from wire and microcatheter manipulations during endovascular procedures. Several definitions of ICH secondary to thrombolysis currently exist, depending on clinical or radiological characteristics used. Multiple studies have investigated clinical and laboratory risk factors associated with higher rates of ICH in this setting. Early ischemic changes seen on noncontrast CT scanning are strongly associated with higher rates of hemorrhage. Modern imaging techniques, particularly CT perfusion, provide rapid assessment of hemodynamic parameters of the brain. Specific patterns of CT perfusion maps can help identify patients who are likely to benefit from revascularization or to develop hemorrhagic complications. There are no established guidelines that describe management of revascularization therapy-induced ICH, and great variability in treatment protocols currently exist. General principles that apply to the management of spontaneous ICH might not be as effective for revascularization therapy-induced ICH. In this article, the authors review current knowledge of risk factors and radiological predictors of ICH secondary to stroke revascularization techniques and analyze medical and surgical management strategies for ICH in this setting.
No takes yet. Share an insight, caveat, or question.
Mokin et al. (2012) conducted a review in Intracerebral hemorrhage secondary to acute ischemic stroke revascularization therapies. Intravenous and endovascular intraarterial revascularization therapies was evaluated. Systemic thrombolysis for acute ischemic stroke can induce intracerebral hemorrhage typically within 24-36 hours of treatment initiation, requiring complex and highly variable management strategies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: